ARCHIVES

In Brief: Forel Retires As Dana-Farber Director, Successor Is David Livingston; Benacerraf Plans Departure

This article is from The Cancer Letter archive.

Vol. 17 No. 27 | July 5, 1991

Download PDF Visit The Full Archive

Related Articles

Salick Raises Nearly $50 Million, Proceeding With FCC Development

June 6, 1986

An Earmark In The Making? NCI Urged to Boost Gastric Cancer Funding

December 17, 2013

Iniparib Plus Chemo Shows Benefit In Phase II Study

January 28, 2011

Iressa Shrinks Some Lung Tumors, Reduces Symptoms In Phase II Trial

June 28, 2002

Schmidt Already Working For NIH Despite His Opposition To Kennedy’s New Research Panel

April 12, 1974

Intermittent Androgen Deprivation Therapy Not Equal to Continuous Treatment, Study Finds

April 26, 2013